Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

156.15 -1.10 (-0.70%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
99 100 Next >
Why Sarepta Therapeutics Stock Is Rising Today
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap 400. 
Via Benzinga
Topics Stocks
Exposures US Equities
3 Stocks That Could Be Easy Wealth Builders
These investment ideas should help you grow your portfolio with minimal effort. 
Via The Motley Fool
Blue-Chip Bubble Trouble: 7 Stocks to Short as Valuations Stretch to the Limit
Be careful with these overvalued blue-chip stocks, each of which is trading at a high multiple relative to its peers. 
Via InvestorPlace
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial
Johnson & Johnson reported successful Phase 3 trial results for seltorexant, an investigational treatment for major depressive disorder with insomnia. 
Via Benzinga
Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare
Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest wealth transfer in history. 
Via Benzinga
Topics Economy Retirement
Exposures Economy Pension
What the Options Market Tells Us About Johnson & Johnson
Via Benzinga
NYSE:JNJ: good value for what you're paying.
JOHNSON & JOHNSON (NYSE:JNJ) is probably undervalued for the fundamentals it is displaying. 
Via Chartmill
HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom
With innovations constantly being developed in the healthcare space, investors should target these medical technology stocks. 
Via InvestorPlace
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis
From Numab Therapeutics AG
Via GlobeNewswire
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
From Johnson & Johnson
Via Business Wire
10 Best Vanguard Funds to Buy Right Now
These 10 Vanguard stock ETFs can help you build a top-notch portfolio. 
Via The Motley Fool
Topics ETFs
Expert Ratings For Johnson & Johnson
Via Benzinga
Smart Money Is Betting Big In JNJ Options
Via Benzinga
7 Dividend Stocks That Could Soar After Q1 Earnings Reports
Take a look at the seven dividend stocks to buy if you are here for passive income and capital gains in the near-term. 
Via InvestorPlace
5 Magnificent Stocks Being Bought for Warren Buffett's $646 Million "Secret" Portfolio
Warren Buffett's secret portfolio contains 90 securities -- five of which are phenomenal businesses whose shares were purchased in the March-ended quarter. 
Via The Motley Fool
3 Dow Stocks to Buy on the Dip: May 2024
Looking for Dow stocks to buy on the dip can be a risky proposition but quite lucrative if done correctly. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
3 Stocks to Safeguard Your Investments During a Market Meltdown
Discover how investing in these leading defensive stocks in pharmaceuticals and restaurants can shield portfolios against market downturns. 
Via InvestorPlace
The Time Traveler’s Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034
These long-term stocks to buy may seem speculative today, but so did Nvidia in 2024 -- and they may match the chipmaker's returns by 2034. 
Via InvestorPlace
Inquiry Into Johnson &amp; Johnson's Competitor Dynamics In Pharmaceuticals Industry
Via Benzinga
DD Stock Separation Plan: What to Know as DuPont Splits Into 3 Companies
DD stock is eyeing some modest gains today after DuPont announced plans to split its electronics and water units from its core business. 
Via InvestorPlace
Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
U.S. Supreme Court urged by Biden administration to reconsider terrorism funding ruling involving major pharmaceutical and medical equipment companies accused of supporting terrorism in Iraq. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Johnson & Johnson's Bankruptcy Tactics Are Fraudulent, Plaintiffs Accuse Company Of Defrauding Cancer Victims
Cancer victims have filed a lawsuit against Johnson & Johnson, accusing the company of fraudulently using a shell company's bankruptcy to evade lawsuits. The plaintiffs claim the "Texas two-step"... 
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
The 500 Top Stocks to Buy in May, According to AI
MarketMaster AI tells us that the top stocks to buy in May represent high-quality companies with strong fundamentals. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Safe-Haven Stocks to Weather Any Storm
Explore top safe-haven stocks to buy now for stability and consistent growth during economic turbulence and uncertainty. 
Via InvestorPlace
7 Dividend Kings to Buy for Royal Passive Income: May Edition
Although they’re not the most exciting entities, these dividend kings to buy benefit from decades of proven performances. 
Via InvestorPlace
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Johnson & Johnson Stock
Johnson & Johnson is a high-quality dividend stock. 
Via The Motley Fool
The AI Stock Underdogs: 7 Underappreciated Companies Poised for Greatness
Although the usual suspects grab the digital intelligence headlines, these underappreciated AI stocks deserve a closer look. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). 
Via Benzinga
Topics Cannabis
Exposures Cannabis
7 Value Stocks to Buy and Hold for a Decade of Dominance
Discover the enduring value of seven key value stocks to buy and hold in diverse sectors, presenting unparalleled opportunities. 
Via InvestorPlace
3 Cheap Healthcare Stocks to Buy Now: May 2024
Healthcare is cheaper than the market and has secular growth tailwinds, meaning these cheap healthcare stocks have upside. 
Via InvestorPlace
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.